The 37th International Conference on Antiviral Research (ICAR 2024) is dedicated to the latest advancements and breakthroughs in antiviral research.
The 37th International Conference on Antiviral Research (ICAR 2024) covers topics such as:
- Broad Spectrum Antiviral Drugs, Non-respiratory Biothreat Viruses, and Pandemic Preparedness
- Arboviruses
- Coronaviruses, Influenza, RSV, and Other Respiratory Viruses
- Chronic, Latent, and Persistent Viruses - Retroviruses and Herpesviruses
- Hepatotropic and GI Viruses
The 37th International Conference on Antiviral Research (ICAR 2024) brings together scientists, researchers, and industry professionals from:
- Startups
- Academia
- Industry
- Small, medium and large pharmaceutical companies
- Governmental and nongovernmental organizations
- Areas of critical importance for immediate or future antiviral development